Your request to link to rcsb for Butyrylcholinesterase%20(BChE)

• 1P0I: crystal structure of human butyryl cholinesterase (10.1074/JBC.M210241200 )
• 1P0M: crystal structure of human butyryl cholinesterase in complex with a choline molecule (10.1074/JBC.M210241200 )
• 1P0P: crystal structure of soman-aged human butyryl cholinesterase in complex with the substrate analog butyrylthiocholine (10.1074/JBC.M210241200 )
• 1P0Q: crystal structure of soman-aged human butyryl cholinesterase (10.1074/JBC.M210241200 )
• 1XLU: x-ray structure of di-isopropyl-phosphoro-fluoridate (dfp) inhibited butyrylcholinesterase after aging (10.1021/BI048238D )
• 1XLV: ethylphosphorylated butyrylcholinesterase (aged) obtained by reaction with echothiophate (10.1021/BI048238D )
• 1XLW: diethylphosphorylated butyrylcholinesterase (nonaged) obtained by reaction with echothiophate (10.1021/BI048238D )
• 2J4C: structure of human butyrylcholinesterase in complex with 10mm hgcl2 (10.1111/J.1742-4658.2007.05732.X )
• 2PM8: crystal structure of recombinant full length human butyrylcholinesterase (10.1107/S1744309107037335 )
• 2WID: nonaged form of human butyrylcholinesterase inhibited by tabun analogue ta1 (10.1042/BJ20090091 )
• 2WIF: aged form of human butyrylcholinesterase inhibited by tabun analogue ta1 (10.1042/BJ20090091 )
• 2WIG: nonaged form of human butyrylcholinesterase inhibited by tabun analogue ta4 (10.1042/BJ20090091 )
• 2WIJ: nonaged form of human butyrylcholinesterase inhibited by tabun analogue ta5 (10.1042/BJ20090091 )
• 2WIK: nonaged form of human butyrylcholinesterase inhibited by tabun analogue ta6 (10.1042/BJ20090091 )
• 2WIL: aged form of human butyrylcholinesterase inhibited by tabun analogue ta5 (10.1042/BJ20090091 )
• 2WSL: aged form of human butyrylcholinesterase inhibited by tabun analogue ta4 (10.1042/BJ20090091 )
• 2XMB: g117h mutant of human butyrylcholinesterase in complex with sulfate (10.1042/BJ20101648 )
• 2XMC: g117h mutant of human butyrylcholinesterase in complex with fluoride anion (10.1042/BJ20101648 )
• 2XMD: g117h mutant of human butyrylcholinesterase in complex with echothiophate (10.1042/BJ20101648 )
• 2XMG: g117h mutant of human butyrylcholinesterase in complex with vx (10.1042/BJ20101648 )
• 2XQF: x-ray structure of human butyrylcholinesterase inhibited by racemic vx (10.1074/JBC.M110.209569 )
• 2XQG: x-ray structure of human butyrylcholinesterase inhibited by racemic vr (10.1074/JBC.M110.209569 )
• 2XQI: x-ray structure of human butyrylcholinesterase inhibited by racemic cvx (10.1074/JBC.M110.209569 )
• 2XQJ: x-ray structure of human butyrylcholinesterase inhibited by pure enantiomer vx-(r) (10.1074/JBC.M110.209569 )
• 2XQK: x-ray structure of human butyrylcholinesterase inhibited by pure enantiomer vx-(s) (10.1074/JBC.M110.209569 )
• 2Y1K: structure of human butyrylcholinesterase inhibited by cbdp (12h soak): phosphoserine adduct (10.1021/TX100447K )
• 3DJY: nonaged form of human butyrylcholinesterase inhibited by tabun (10.1021/JA804941Z )
• 3DKK: aged form of human butyrylcholinesterase inhibited by tabun (10.1021/JA804941Z )
• 3O9M: co-crystallization studies of full length recombinant bche with cocaine offers insights into cocaine detoxification (10.1107/S1744309111004805 )
• 4AQD: crystal structure of fully glycosylated human butyrylcholinesterase (10.1111/J.1742-4658.2012.08672.X )
• 4AXB: crystal structure of soman-aged human butyrylcholinesterase in complex with 2-pam (10.1016/J.CBI.2012.08.005 )
• 4B0O: crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-methyltrichloroacetimidate (10.1016/J.CBI.2012.08.005 )
• 4B0P: crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobenzyloxyimino)pyridinium (10.1016/J.CBI.2012.08.005 )
• 4BBZ: structure of human butyrylcholinesterase inhibited by cbdp (2-min soak): cresyl-phosphoserine adduct (10.1021/TX3004505 )
• 4BDS: human butyrylcholinesterase in complex with tacrine (10.1042/BJ20130013 )
• 4TPK: human butyrylcholinesterase in complex with n-((1-(2,3-dihydro-1h- inden-2-yl)piperidin-3-yl)methyl)-n-(2-methoxyethyl)-2-naphthamide (10.1021/JM501195E )
• 4XII: x-ray structure of human butyrylcholinesterase in complex with n-((1- (2,3-dihydro-1h-inden-2-yl)piperidin-3-yl)methyl)-8-hydroxy-n-(2- methoxyethyl)-5-nitroquinoline-7-carboxamide (10.1016/J.BMC.2015.06.010 )
• 5DYT: crystal structure of human butyrylcholinesterase in complex with n- ((1-benzylpiperidin-3-yl)methyl)-n-methylnaphthalene-2-sulfonamide (10.1038/SREP39495 )
• 5DYW: crystal structure of human butyrylcholinesterase in complex with n- ((1-benzylpiperidin-3-yl)methyl)-n-(2-methoxyethyl)naphthalene-2- sulfonamide (10.1038/SREP39495 )
• 5DYY: crystal structure of human butyrylcholinesterase in complex with n- ((1-benzylpiperidin-3-yl)methyl)naphthalene-2-sulfonamide (10.1038/SREP39495 )
• 5K5E: discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening (10.1021/ACS.JMEDCHEM.6B00356 )
• 5LKR: human butyrylcholinesterase complexed with n-propargyliperidines (10.1016/J.BMC.2016.11.032 )
• 5NN0: crystal structure of hubche with n-((1-(2,3-dihydro-1h-inden-2-yl) piperidin-3-yl)methyl)-n-(2-(dimethylamino)ethyl)-2-naphthamide. (10.1021/ACS.JMEDCHEM.7B01086 )
• 6EMI: crystal structure of a variant of human butyrylcholinesterase expressed in bacteria. (10.3390/MOLECULES22111828 )
• 6EP4: human butyrylcholinesterase in complex with decamethonium (10.3390/MOLECULES22122098 )
• 6EQP: human butyrylcholinesterase in complex with ethopropazine (10.3390/MOLECULES22122098 )
• 6EQQ: human butyrylcholinesterase in complex with huprine 19 (10.3390/MOLECULES22122098 )
• 6ESJ: human butyrylcholinesterase in complex with propidium (10.3390/MOLECULES22122098 )
• 6ESY: human butyrylcholinesterase in complex with thioflavine t (10.3390/MOLECULES22122098 )
• 6EUL: butyrylcolinesterase expressed in cho cells co-crystallised with a rivastigmine analogue (10.1038/S42004-019-0133-4 )
• 6EYF: butyrylcolinesterase expressed in cho cells co-crystallised with a rivastigmine analogue (10.1038/S42004-019-0133-4 )
• 6EZ2: human butyrylcholinesterase carbamylated. (10.1038/S42004-019-0133-4 )
• 6F7Q: human butyrylcholinesterase complexed with n-propargyliperidines (10.1016/J.EJMECH.2018.07.033 )
• 6I0B: human butyrylcholinesterase in complex with the s enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. (10.1016/J.EJMECH.2019.02.021 )
• 6I0C: human butyrylcholinesterase in complex with the r enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. (10.1016/J.EJMECH.2019.02.021 )
• 6I2T: cryoem reconstruction of full-length, fully-glycosylated human butyrylcholinesterase tetramer (10.1073/PNAS.1817009115 )
• 6QAA: human butyrylcholinesterase in complex with (s)-2-(butylamino)-n-(2- cycloheptylethyl)-3-(1h-indol-3-yl)propanamide (10.1039/C9CC01330J )
• 6QAB: human butyrylcholinesterase in complex with (s)-n-(1-((2- cycloheptylethyl)amino)-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-n,n- dimethylbutan-1-aminium (10.1039/C9CC01330J )
• 6QAC: human butyrylcholinesterase in complex with (s)-2-(butylamino)-n-(3- cycloheptylpropyl)-3-(1h-indol-3-yl)propanamide (10.1039/C9CC01330J )
• 6QAD: human butyrylcholinesterase in complex with ((s)-2-(butylamino)-n-(2- (4-(dimethylamino)cyclohexyl)ethyl)-3-(1h-indol-3-yl)propanamide (10.1039/C9CC01330J )
• 6QAE: human butyrylcholinesterase in complex with (s)-n2-butyl-n1-(2- cycloheptylethyl)-3-(1h-indol-3-yl)-n1,n2-dimethylpropane-1,2-diamine (10.1039/C9CC01330J )
• 6R6V: structure of recombinant human butyrylcholinesterase in complex with a fluorescent coumarin-based probe (10.1080/14756366.2019.1710502 )
• 6R6W: structure of recombinant human butyrylcholinesterase in complex with a fluorescent nbd-based probe (10.1080/14756366.2019.1710502 )
• 6RUA: structure of recombinant human butyrylcholinesterase in complex with a coumarin-based fluorescent probe linked to sulfonamide type inhibitor. (10.1080/14756366.2019.1710502 )
• 6SAM: structure of human butyrylcholinesterase in complex with 1-(2,3- dihydro-1h-inden2-yl)piperidin-3-yl n-phenyl carbamate (10.1016/J.EJMECH.2020.112282 )
• 6T9P: human butyrylcholinesterase in complex with 2-(n-hydroxyimino)-n- [(1r)-3-{4-[(2-methyl-1h-imidazol-1-yl)methyl]-1h-1,2,3-triazol-1- yl}-1- phenylpropyl]acetamide (10.1042/BCJ20200192 )
• 6T9S: human butyrylcholinesterase in complex with 2-(n-hydroxyimino)-n- [(1s)-3-{4-[(2-methyl-1h-imidazol-1-yl)methyl]-1h-1,2,3-triazol-1- yl}-1- phenylpropyl]acetamide (10.1042/BCJ20200192 )
• 6XTA: recombinant human butyrylcholinesterase in complex with (2s)-n-[2-(1- benzylazepan-4-yl)ethyl]-2-(butylamino)-3-(1h-indol-3-yl)propanamide (10.1016/J.EJMECH.2020.112766 )
• 6ZWI: human butyrylcholinesterase in complex with ((6-((2e,4e)-5- (benzo[d][1,3]dioxol-5-yl)penta-2,4-dienamido)hexyl) triphenylphosphonium bromide) (10.3390/ANTIOX10020329 )
• 7AIY: crystal structure of human butyrylcholinesterase in complex with 2-{1- [4-(12-amino-3-chloro-6,7,10,11-tetrahydro-7,11- methanocycloocta[b]quinolin-9-yl)butyl]-1h-1,2,3-triazol-4-yl}-n-[4- hydroxy-3-methoxybenzyl]acetamide
• 7AMZ: crystal structure of human butyrylcholinesterase in complex with n- ((2s,3r)-4-((2,2-dimethylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)- 2,2-diphenylacetamide (10.1016/J.EJMECH.2021.113397 )
• 7AWG: crystal structure of human butyrylcholinesterase in complex with (2- ((1-(benzenesulfonyl)-1h-indol-4-yl)oxy)ethyl)(benzyl)amine (10.1016/J.EJMECH.2021.113792 )
• 7AWH: crystal structure of human butyrylcholinesterase in complex with tert- butyl 3-(((2-((1-(benzenesulfonyl)-1h-indol-4-yl)oxy)ethyl)amino) methyl)piperidine-1-carboxylate (10.1016/J.EJMECH.2021.113792 )
• 7AWI: crystal structure of human butyrylcholinesterase in complex with tert- butyl 3-(((2-((1-benzyl-1h-indol-4-yl)oxy)ethyl)amino) methyl]piperidine-1-carboxylate (10.1016/J.EJMECH.2021.113792 )
• 7BGC: human butyrylcholinesterase in complex with a tacrine-methylanacardate hybrid inhibitor (10.1021/ACS.JMEDCHEM.1C00048 )
• 7BO3: human butyrylcholinesterase in complex with n-(2-(1h-indol-3-yl) ethyl)-2-cycloheptyl-n-methylethan-1-amine (10.1016/J.EJMECH.2022.114248 )
• 7BO4: human butyrylcholinesterase in complex with 3-(2-(butyl(2- cycloheptylethyl)amino)ethyl)-1h-indol-6-ol (10.1016/J.EJMECH.2022.114248 )